Peptic Ulcer Market Emerging Trends and Growth Drivers Through 2029 | Reach Billion

 Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the peptic ulcer sector.

 

 How Large Will The Peptic Ulcer Market Be By 2025?
 The peptic ulcer market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.22 billion in 2025 at a compound annual growth rate (CAGR) of 3.0%. The growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.
 
 The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalities, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp
 
 What Are Key Factors Driving The Demand In The Global Peptic Ulcer Market?
 The growing prevalence of obesity is expected to propel the growth of the peptic ulcer market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, typically resulting in an individual having a body mass index (BMI) of 30 or higher. Obesity can result from genetic, environmental, and lifestyle factors, such as a poor diet and a lack of physical activity. Obesity leads to the overproduction of stomach acid, weakens the stomach’s protective mucosal lining, and contributes to developing peptic ulcers. Moreover, excess weight seems to promote inflammation in the gut, which can lead to the development of peptic ulcers. For instance, in September 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, between August 2021 and August 2023, the prevalence of obesity among adults was 40.3%, with 39.2% in men and 41.3% in women. Therefore, the growing prevalence of obesity is driving the growth of the peptic ulcer market.
 
 Comparative Analysis Of Leading Peptic Ulcer Market Segments
 The peptic ulcermarket covered in this report is segmented — 
 
 1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
 2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
 3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-Commerce
 
 Subsegments:
 1) By Gastritis: Acute Gastritis; Chronic Gastritis 
 2) By Gastric Ulcer: Acute Gastric Ulcer; Chronic Gastric Ulcer 
 3) By Duodenal Ulcer: Acute Duodenal Ulcer; Chronic Duodenal Ulcer 
 4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD; Erosive GERD
 
 What Are The Key Trends Shaping The Peptic Ulcer Industry?
 Companies operating in the peptic ulcer market are developing innovative products and solutions and getting them approved by federal agencies to gain a competitive edge. Drug development is crucial in managing and treating peptic ulcers. It aids in symptom management, healing, preventing complications, and treating the underlying problem. For instance, in April 2023, Akums Drugs and Pharmaceutical Ltd., an India-based pharmaceutical formulations and active pharmaceutical ingredients (APIs) company, launched its latest formulation, the Combikit, which combines Amoxicillin, Clarithromycin, and Esomeprazole. This Combikit has received approval from the Central Drugs Standard Control Organisation (CDSCO) for treating duodenal ulcers linked to Helicobacter pylori (H. pylori) and for eradicating H. pylori in patients with active or healed peptic ulcers. The therapy targeting H. pylori has proven effective in reducing the risk of ulcer recurrence, offering significant benefits to patients. H. pylori is a prevalent infection in India and is associated with the development of gastritis and peptic ulcers. 
 
 Who Are The Prominent Players In The Peptic Ulcer Business?
 Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.
 
 View the full peptic ulcer market report here:
 https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report
 
 Which Region Is Expected To Lead The Peptic Ulcer Market By 2025?
 North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company